Australia - English - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - folic acid, quantity: 0.35 mg; ferrous fumarate, quantity: 310 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; povidone; titanium dioxide; iron oxide red; microcrystalline cellulose; purified talc; sodium starch glycollate type a; hypromellose; magnesium stearate; triethyl citrate - to be given as a source of iron and folic acid for the prevention and treatment of iron and folic acid deficiency anaemias. it may also be used for the prevention and treatment of these conditions during pregnancy.

Bangladesh - English - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 200 mcg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 400 mcg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

sharif pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 200 mcg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

sharif pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 400 mcg

United States - English - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 151 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy. folic acid is contraindicated in patients with pernicious anemia (see precautions). soybean oil, lecithin, di calcium phosphate anhydrous, beeswax yellow, hydrogenated soybean oil.

United States - English - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 66 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy. folic acid is contraindicated in patients with pernicious anemia (see precautions).

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), pyridoxine (unii: kv2jz1bi6z) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), calcium (unii: sy7q814vup) (calcium - unii:sy7q814vup), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), magnesium (unii: i38zp9992a) (magnesium - unii:i38zp9992a), doconexent (unii: zad9okh9jc) (doconexent - unii:zad9okh9jc) - ascorbic acid 85 [iu] - description: pnv-dha is a prescription prenatal/postnatal multivitamin/mineral/essential fatty acid softgel. each softgel is blue in color, opaque and imprinted with “bp 321” on one side. other ingredients: bee’s wax, hydrogenated vegetable oil, lecithin, gelatin, glycerin, purified water, titanium dioxide, fd&c blue #1, fd&c red #3. indications: pnv-dha is a multivitamin/multimineral nutritional supplement indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation. contraindications: this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Australia - English - Department of Health (Therapeutic Goods Administration)

nature's family australia pty ltd - biotin,calcium pantothenate,cyanocobalamin,ferrous fumarate,folic acid,iodine,nicotinamide,pyridoxine,riboflavin,thiamine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

star combo australia pty ltd - ascorbic acid,calcium hydrogen phosphate dihydrate,cyanocobalamin,ferrous fumarate,folic acid,nicotinamide,pyridoxine hydrochloride,riboflavine,thiamine -